Modulation of drug-induced apoptosis by interruption of the protein kinase C signal transduction pathway: a new therapeutic strategy.
Grant
S
S
Departments of Medicine and Pharmacology and Toxicology, Medical College of Virginia, Richmond, Virginia 23298, USA.
Jarvis
W D
WD
D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis; D054713:Bryostatins; D003561:Cytarabine / Q000627:therapeutic use; D004357:Drug Synergism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D018942:Macrolides; D009369:Neoplasms / Q000188:drug therapy / Q000201:enzymology; D011493:Protein Kinase C / Q000037:antagonists & inhibitors*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D015398:Signal Transduction
D000970:Antineoplastic Agents; D054713:Bryostatins; D004791:Enzyme Inhibitors; D007783:Lactones; D018942:Macrolides; D003561:Cytarabine; C046785:bryostatin 1; D011505:Protein-Tyrosine Kinases; D011493:Protein Kinase C